COVID-19 drug practices risk antimicrobial resistance evolution

MetaSUB Consortium

doi:10.1016/S2666-5247(21)00039-2

COVID-19 drug practices risk antimicrobial resistance evolution

MetaSUB Consortium

School of Life Sciences

Cornell University
Instituto Nacional de Salud Publica
Universidad Andrés Bello
University of Hawai'i at Mānoa
Aix-Marseille Université
Universidade de São Paulo
Lund University
Institut Pasteur Montevideo
Institut Pasteur Korea
Jagiellonian University in Kraków
National University of Singapore
University of Copenhagen
City University of New York
University of Medicine and Health Sciences
American University in Cairo
Keio University
University of Tübingen
Universidad Central
Indian Statistical Institute

Research output: Contribution to journal › Comment/debate

63 Scopus citations

Original language	English
Pages (from-to)	e135-e136
Journal	The Lancet Microbe
Volume	2
Issue number	4
DOIs	https://doi.org/10.1016/S2666-5247(21)00039-2
State	Published - Apr 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S2666-5247(21)00039-2

Cite this

@article{294339298f4946dd94be56cdad03bd57,

title = "COVID-19 drug practices risk antimicrobial resistance evolution",

author = "\{MetaSUB Consortium\} and Ebrahim Afshinnekoo and Chandrima Bhattacharya and Ana Burguete-Garc{\'i}a and Eduardo Castro-Nallar and Youping Deng and Christelle Desnues and Emmanuel Dias-Neto and Eran Elhaik and Gregorio Iraola and Soojin Jang and {\L}abaj, \{Pawe{\l} P.\} and Mason, \{Christopher E.\} and Niranjan Nagarajan and Michael Poulsen and Bharath Prithiviraj and Rania Siam and Tieliu Shi and Haruo Suzuki and Johannes Werner and Zambrano, \{Maria Mercedes\} and Malay Bhattacharyya",

year = "2021",

month = apr,

doi = "10.1016/S2666-5247(21)00039-2",

language = "英语",

volume = "2",

pages = "e135--e136",

journal = "The Lancet Microbe",

issn = "2666-5247",

publisher = "Elsevier Ltd",

number = "4",

}

TY - JOUR

T1 - COVID-19 drug practices risk antimicrobial resistance evolution

AU - MetaSUB Consortium

AU - Afshinnekoo, Ebrahim

AU - Bhattacharya, Chandrima

AU - Burguete-García, Ana

AU - Castro-Nallar, Eduardo

AU - Deng, Youping

AU - Desnues, Christelle

AU - Dias-Neto, Emmanuel

AU - Elhaik, Eran

AU - Iraola, Gregorio

AU - Jang, Soojin

AU - Łabaj, Paweł P.

AU - Mason, Christopher E.

AU - Nagarajan, Niranjan

AU - Poulsen, Michael

AU - Prithiviraj, Bharath

AU - Siam, Rania

AU - Shi, Tieliu

AU - Suzuki, Haruo

AU - Werner, Johannes

AU - Zambrano, Maria Mercedes

AU - Bhattacharyya, Malay

PY - 2021/4

Y1 - 2021/4

UR - https://www.scopus.com/pages/publications/85103372304

U2 - 10.1016/S2666-5247(21)00039-2

DO - 10.1016/S2666-5247(21)00039-2

M3 - 评论/辩论

AN - SCOPUS:85103372304

SN - 2666-5247

VL - 2

SP - e135-e136

JO - The Lancet Microbe

JF - The Lancet Microbe

IS - 4

ER -

COVID-19 drug practices risk antimicrobial resistance evolution

UN SDGs

Access to Document

Other files and links

Cite this